Macrophage activation syndrome treated with anakinra.
Durand
Madeleine
M
Troyanov
Yves
Y
Laflamme
Pierre
P
Gregoire
Genevieve
G
D000328:Adult; D018501:Antirheumatic Agents / Q000627:therapeutic use; D005260:Female; D006801:Humans; D053590:Interleukin 1 Receptor Antagonist Protein / Q000627:therapeutic use*; D055501:Macrophage Activation Syndrome / Q000188:drug therapy*; D016896:Treatment Outcome
D018501:Antirheumatic Agents; D053590:Interleukin 1 Receptor Antagonist Protein